Page last updated: 2024-08-16

sibutramine and peptide yy

sibutramine has been researched along with peptide yy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gura, T1
Ametov, AS; Vlasova, IuIu1
Al-Zaman, Y; Aylwin, S1

Reviews

1 review(s) available for sibutramine and peptide yy

ArticleYear
Emerging concepts in the medical and surgical treatment of obesity.
    Frontiers of hormone research, 2008, Volume: 36

    Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide

2008

Trials

1 trial(s) available for sibutramine and peptide yy

ArticleYear
[Effect of sibutramine (meridia) on body composition, peptide YY3-36 and serotonin levels in patients with exogenous constitutional obesity].
    Terapevticheskii arkhiv, 2010, Volume: 82, Issue:8

    Topics: Adult; Anthropometry; Appetite Depressants; Body Composition; Body Weight; Combined Modality Therapy; Cyclobutanes; Female; Humans; Male; Obesity; Peptide Fragments; Peptide YY; Serotonin; Treatment Outcome

2010

Other Studies

1 other study(ies) available for sibutramine and peptide yy

ArticleYear
Obesity drug pipeline not so fat.
    Science (New York, N.Y.), 2003, Feb-07, Volume: 299, Issue:5608

    Topics: Agouti-Related Protein; alpha-MSH; Animals; Anti-Obesity Agents; Appetite; Arcuate Nucleus of Hypothalamus; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Energy Intake; Ghrelin; Humans; Hunger; Intercellular Signaling Peptides and Proteins; Lactones; Leptin; Mice; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Obesity; Orlistat; Peptide Fragments; Peptide Hormones; Peptide YY; Phentermine; Proteins; Receptors, Corticotropin; Receptors, Melanocortin; Weight Loss

2003